Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hosted on MSN
1h
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail
Biogen Inc. shares climbed 1.7% on Monday afternoon, reaching a nearly two-week high, as positive regulatory news countered ...
Hosted on MSN
44m
Eisai and Biogen’s Leqembi sBLA set for Alzheimer’s maintenance dosing
The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Tech stocks fall
Taliban envoy warns Rubio
Car plows into Eagles fans
NY state trooper surrenders
Air Force reinstates course
Graham on Jan. 6 pardons
Swaps Pepsi for Coca-Cola
Texas nightclub shooting
Immigration raids across TX
To limit public schedule
Suspect to appear in court
Colombia tariffs paused
Lilleberg faces NHL hearing
House explosion in W.Va.
SK plane crash probe
‘Flight Risk’ tops box office
New OC for Seahawks
Belarus releases US citizen
ND trans care ban trial
Won't review MS voting ban
Sinner wins Australian Open
H5N9 outbreak in poultry
Israel permits Gaza return
Proposes TikTok merger
Emil Bove visits Chicago
NK tested cruise missiles?
Chiefs beat Bills
Eagles defeat Commanders
Related topics
Sage Therapeutics
Eisai
United States
Leqembi
Spinraza
Feedback